title: Immunoblastic lymphoma with abundant clear cytoplasm. A comparative study of B- and T-cell types.
abstract: The morphologic, phenotypic, molecular genetic, and clinical features of 34 cases of clear-cell immunoblastic lymphoma (IBLC) are described. Sixteen cases were of B-cell type (IBLC-B) and 18 cases were of T-cell type (IBLC-T). There were no significant differences in the morphologic characteristics of the neoplastic cells in the two types, although IBLC-B was less likely to be polymorphic than IBLC-T. Interfollicular proliferation, a higher mitotic rate, infiltration by eosinophils, and an increase in capillary-sized blood vessels were also features of IBLC-T, whereas necrosis and fibrosis were more extensive in IBLC-B. Patients with IBLC-B were predominantly female, whereas those with IBLC-T were predominantly male. The mean age was 62 years for those with IBLC-B and 46 years for those with IBLC-T. Patients with IBLC-B usually had lower-stage disease, but there was no significant difference in survival rate between those with IBLC-B and those with IBLC-T. Although most cases of IBLC have been considered to be of peripheral T-cell origin, the authors conclude that IBLC-B is more common than previously considered and that clear-cell morphologic characteristics are not a reliable indicator of T-cell type.
authors.affiliation: Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198-3135.
authors.forename: H
authors.initials: H
authors.lastname: Nakamine
authors.forename: A S
authors.initials: AS
authors.lastname: Masih
authors.forename: R S
authors.initials: RS
authors.lastname: Strobach
authors.forename: M J
authors.initials: MJ
authors.lastname: Duggan
authors.forename: M A
authors.initials: MA
authors.lastname: Bast
authors.forename: J O
authors.initials: JO
authors.lastname: Armitage
authors.forename: D D
authors.initials: DD
authors.lastname: Weisenburger
mesh_terms: D003593:Cytoplasm / Q000648:ultrastructure*; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D007150:Immunohistochemistry; D016393:Lymphoma, B-Cell / Q000473:pathology*; D016399:Lymphoma, T-Cell / Q000473:pathology*; D008297:Male; D010641:Phenotype; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D016019:Survival Analysis